If your .02 call is correct that gives him a little over $3 million in compensation and countless hours setting himself and the company up to fail. He had a much better job and a substantially higher pay package. And yet he came to ELTP, for, according to your valuation, for a company that will never be more than a .02 company. Methinks someone did not think the job change through.
I agree with NH that the revenue of all the generics will be breadcrumbs compared to the possible ADT revenue soon to be achieved. You have not answered the question about the cost of getting an ANDA approved. ..